newsfilter
← Latest News
GlobeNewswire·

Oculis to Host In-Person and Virtual R&D Day: Advancing a Differentiated Late-Stage Development Pipeline

ZUG, Switzerland, November 9, 2026 -- Oculis Holding AG (NASDAQ:OCS, XICE: OCS)) ("Oculis"), a global biopharmaceutical company focused on breakthrough innovations in neuro-ophthalmology and ophthalmology, today